Sinovac Biotech

$6.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch SVA and buy or sell other stocks, options, and ETFs commission-free!

About SVA

Sinovac Biotech, Ltd. Ordinary Shares, also called Sinovac Biotech, is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases.

CEO
Wei Dong Yin
Employees
910
Headquarters
Beijing, Beijing
Founded
1993
Market Cap
460.27M
Price-Earnings Ratio
34.18
Dividend Yield
—
Average Volume
—
High Today
—
Low Today
—
Open Price
—
Volume
0.00
52 Week High
$8.75
52 Week Low
$5.73

SVA News

ReutersApr 8

Egypt to produce up to 80 million Sinovac vaccine doses annually, minister says

FILE PHOTO: Egypt's Health Minister Hala Zayed speaks during a news conference announcing the details of a vaccination campaign against the coronavirus disease

SVA Earnings

-$0.07
$0.02
$0.12
$0.21
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 29, Pre-Market

You May Also Like

CAS+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure